Itolizumab demonstrated clinical efficacy after 12 weeks of treatment, achieving a clinical remission rate of 23.3% compared ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...

UBS forecasts that Sandoz will likely achieve the lower end of its 24-26% core EBITDA margin target by 2028. To reach the ...

Teaser: Off-label systemic agents may treat inflammatory autoimmune vulvar diseases such as lichen sclerosus and lichen ...

Researchers used an AI-driven approach to identify adalimumab as a potential life-saving treatment for idiopathic ...

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of ...